Atlas Trials

A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.

Clinical trial NCT06806995 · COMPLETED

Trial details

NCT number
NCT06806995
Sponsor
Wockhardt
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
PHA1A
Start date
2025-01-21
Primary completion
2025-02-17
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.